Foresite Capital Management Vi LLC Centessa Pharmaceuticals PLC Transaction History
Foresite Capital Management Vi LLC
- $183 Billion
- Q1 2025
A detailed history of Foresite Capital Management Vi LLC transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, Foresite Capital Management Vi LLC holds 1,253,379 shares of CNTA stock, worth $16.5 Million. This represents 9.87% of its overall portfolio holdings.
Number of Shares
1,253,379
Previous 1,253,379
-0.0%
Holding current value
$16.5 Million
Previous $21 Billion
14.15%
% of portfolio
9.87%
Previous 9.35%
Shares
1 transactions
Others Institutions Holding CNTA
# of Institutions
142Shares Held
124MCall Options Held
163KPut Options Held
816K-
Medicxi Ventures Management (Jersey) LTD20MShares$262 Million75.25% of portfolio
-
Index Venture Life Associates Vi LTD St. Helier, Y99.96MShares$131 Million100.0% of portfolio
-
General Atlantic LLC New York, NY9.68MShares$127 Million4.7% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA6.95MShares$91.3 Million0.19% of portfolio
-
Janus Henderson Group PLC London, X05.92MShares$77.8 Million0.05% of portfolio
About Centessa Pharmaceuticals plc
- Ticker CNTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,339,296
- Market Cap $1.24B
- Description
- Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...